← back to search

Andrei I. Holodny

Memorial Sloan Kettering Cancer Center · US
Area of research
Radiology, Nuclear Medicine and Imaging · Genetics
Research interest
Research interests include Advanced Neuroimaging Techniques and Applications, Advanced MRI Techniques and Applications, Glioma Diagnosis and Treatment, and Functional Brain Connectivity Studies.
h-index
49
citations
7,665
works
296
NIH funding
primary concept
email

Recent publications

CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results
Nature Medicine 2023cited by 159position: middledoi
Recommended Resting-State fMRI Acquisition and Preprocessing Steps for Preoperative Mapping of Language and Motor and Visual Areas in Adult and Pediatric Patients with Brain Tumors and Epilepsy
American Journal of Neuroradiology 2023cited by 17position: middledoi
Understanding Language Reorganization With Neuroimaging: How Language Adapts to Different Focal Lesions and Insights Into Clinical Applications
Frontiers in Human Neuroscience 2022cited by 46position: lastdoi
Brain Functional Connectivity in Low- and High-Grade Gliomas: Differences in Network Dynamics Associated with Tumor Grade and Location
Cancers 2022cited by 41position: lastdoi
Integrating Eye Tracking and Speech Recognition Accurately Annotates MR Brain Images for Deep Learning: Proof of Principle
Radiology Artificial Intelligence 2020cited by 29position: middledoi
Glioma-Induced Disruption of Resting-State Functional Connectivity and Amplitude of Low-Frequency Fluctuations in the Salience Network
American Journal of Neuroradiology 2020cited by 20position: middledoi
Core language brain network for fMRI language task used in clinical applications
Network Neuroscience 2019cited by 36position: lastdoi
Metabolic Imaging of the Human Brain with Hyperpolarized 13C Pyruvate Demonstrates 13C Lactate Production in Brain Tumor Patients
Cancer Research 2018cited by 219position: middledoi
fMRI activation in the middle frontal gyrus as an indicator of hemispheric dominance for language in brain tumor patients: a comparison with Broca’s area
Neuroradiology 2016cited by 31position: lastdoi
Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma
Neuro-Oncology 2015cited by 193position: middledoi
Phase II Trial of Temozolomide in Patients with Relapsed Sensitive or Refractory Small Cell Lung Cancer, with Assessment of Methylguanine-DNA Methyltransferase as a Potential Biomarker
Clinical Cancer Research 2012cited by 184position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 5 papers (2016–2023) · 3 papers (2019–2022)Behroze Vachha · UMass Memorial Health Care2 papers (2020–2023)Hernán A. Makse · University of New Mexico1 papers (2019–2019) · 1 papers (2022–2022)Jae H. Park · Memorial Sloan Kettering Cancer Center1 papers (2023–2023)Renier J. Brentjens · Roswell Park Comprehensive Cancer Center1 papers (2023–2023)Greg Zaharchuk · Stanford University1 papers (2023–2023)M. Catherine Pietanza · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2012–2012)Haris I. Sair · New York University1 papers (2023–2023)Jina Lee · Georgetown University1 papers (2023–2023) · 1 papers (2019–2019)Antonio Napolitano · Cambridge University Hospitals NHS Foundation Trust1 papers (2022–2022)Alessandro Bozzao · Tanta University1 papers (2022–2022)Naiyer A. Rizvi · Synthego (United States)1 papers (2012–2012)Nicole Brennan · New York Medical College1 papers (2016–2016)Timothy A. Chan · Cleveland Clinic1 papers (2012–2012)Kety Huberman · Memorial Sloan Kettering Cancer Center1 papers (2012–2012) · 1 papers (2022–2022)Miguel‐Angel Perales · nLIGHT (United States)1 papers (2023–2023)